376 related articles for article (PubMed ID: 15480330)
1. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.
Simon D; Vassina E; Yousefi S; Kozlowski E; Braathen LR; Simon HU
J Allergy Clin Immunol; 2004 Oct; 114(4):887-95. PubMed ID: 15480330
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment.
Simon D; Vassina E; Yousefi S; Braathen LR; Simon HU
Allergy; 2005 Jul; 60(7):944-51. PubMed ID: 15932386
[TBL] [Abstract][Full Text] [Related]
3. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study.
Caproni M; Torchia D; Antiga E; Terranova M; Volpi W; del Bianco E; D'Agata A; Fabbri P
Br J Dermatol; 2007 Feb; 156(2):312-9. PubMed ID: 17223872
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus ointment causes inflammatory dendritic epidermal cell depletion but no Langerhans cell apoptosis in patients with atopic dermatitis.
Schuller E; Oppel T; Bornhövd E; Wetzel S; Wollenberg A
J Allergy Clin Immunol; 2004 Jul; 114(1):137-43. PubMed ID: 15241357
[TBL] [Abstract][Full Text] [Related]
5. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.
Wollenberg A; Sharma S; von Bubnoff D; Geiger E; Haberstok J; Bieber T
J Allergy Clin Immunol; 2001 Mar; 107(3):519-25. PubMed ID: 11240954
[TBL] [Abstract][Full Text] [Related]
6. Epidermal caspase-3 cleavage associated with interferon-gamma-expressing lymphocytes in acute atopic dermatitis lesions.
Simon D; Lindberg RL; Kozlowski E; Braathen LR; Simon HU
Exp Dermatol; 2006 Jun; 15(6):441-6. PubMed ID: 16689860
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
Hingorani M; Calder VL; Buckley RJ; Lightman S
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
[TBL] [Abstract][Full Text] [Related]
8. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A
J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147
[TBL] [Abstract][Full Text] [Related]
9. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis.
Kim HO; Lee CH; Ahn HK; Park CW
Int J Dermatol; 2009 Apr; 48(4):431-8. PubMed ID: 19335435
[TBL] [Abstract][Full Text] [Related]
10. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.
Yawalkar N; Karlen S; Egli F; Brand CU; Graber HU; Pichler WJ; Braathen LR
J Allergy Clin Immunol; 2000 Nov; 106(5):941-7. PubMed ID: 11080718
[TBL] [Abstract][Full Text] [Related]
12. Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment.
Oshio T; Sasaki Y; Funakoshi-Tago M; Aizu-Yokota E; Sonoda Y; Matsuoka H; Kasahara T
Int Immunopharmacol; 2009 Apr; 9(4):403-11. PubMed ID: 19162238
[TBL] [Abstract][Full Text] [Related]
13. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
14. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
[TBL] [Abstract][Full Text] [Related]
15. A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis.
Lehto M; Savinko T; Wolff H; Kvist PH; Kemp K; Lauerma A; Alenius H
Int Immunopharmacol; 2010 Apr; 10(4):377-84. PubMed ID: 20074670
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
17. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
[TBL] [Abstract][Full Text] [Related]
18. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis.
Antúnez C; Torres MJ; Mayorga C; Cornejo-García JA; Santamaría-Babi LF; Blanca M
Clin Exp Allergy; 2004 Apr; 34(4):559-66. PubMed ID: 15080808
[TBL] [Abstract][Full Text] [Related]
19. Mononuclear cells in atopic dermatitis in vivo: immunomodulation of the cutaneous infiltrate by medium-dose UVA1 phototherapy.
Breuckmann F; von Kobyletzki G; Avermaete A; Pieck C; Kreuter A; Brockmeyer NH; Altmeyer P; Gambichler T
Eur J Med Res; 2002 Jul; 7(7):315-22. PubMed ID: 12176681
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus ointment (Protopic) for atopic dermatitis.
Pascual JC; Fleisher AB
Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
